ScholarIQanswers from OpenAlex
Hyogo University
InstitutionResearch output, impact & collaborations
Hyogo University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Hyogo University?
ScholarIQrecord summary
Hyogo University is a research organisation in Kakogawa, JP. OpenAlex records 4,247 works and 68,499 citations for it. 1,817 researchers list it as their most recent affiliation.
How many works does Hyogo University have?
ScholarIQindexed works
Hyogo University has 4,247 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hyogo University have?
ScholarIQcitation count
Hyogo University has 68,499 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Hyogo University?
ScholarIQresearcher count
Hyogo University has 1,817 researchers in the ScholarIQ index.
What is the average h-index at Hyogo University?
ScholarIQavg h-index
Hyogo University has an average h-index of 50.7 in OpenAlex.
What is the ROR of Hyogo University?
ScholarIQror
The ROR for Hyogo University is on the source record.
What is the OpenAlex record for Hyogo University?
ScholarIQopenalex
The OpenAlex for Hyogo University is on the source record.
What is the Wikidata of Hyogo University?
ScholarIQwikidata
The Wikidata for Hyogo University is on the source record.
Who are the most-cited researchers behind Hyogo University?
ScholarIQtop researchers by citations
What are the most-cited papers on Hyogo University?
ScholarIQmost cited works
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
Shunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto, Hayato Kawachi, Munehiro Ito, Yuki Sato, Kazuma Nagata, Atsushi Nakagawa, Kojiro Otsuka, Keiichiro Uehara, Yukihiro Imai, Kaori Shintani‐Ishida, Junya Fukuoka, Keisuke Tomii
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis
Hiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, Yoshinori Iwata, Yuho Miyamoto, Noriko Ishii, Yukihisa Yuri, Kunihiro Hasegawa, Chikage Nakano, Takashi Nishimura, Kazunori Yoh, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Ryo Takata, Hiroko Iijima, Shuhei Nishiguchi
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
Hiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi, Daichi Fujimoto, Motoko Tachihara, Naoki Furuya, Sakiko Otani, Junichi Shimizu, Nobuyuki Katakami, Koichi Azuma, Naoko Miura, Kazumi Nishino, Satoshi Hara, Shunsuke Teraoka, Satoshi Morita, Kazuhiko Nakagawa, Nobuyuki Yamamoto
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
Emina Torlakovic, Hyun J. Lim, Julien Adam, Penny J. Barnes, Gilbert Bigras, Anthony W.H. Chan, Carol C. Cheung, Jin-Haeng Chung, Christian Couture, Pierre Fiset, Daichi Fujimoto, Gang Han, Fred R. Hirsch, Marius Ilié, Diana N. Ionescu, Chao Li, Enrico Munari, Katsuhiro Okuda, M. Ratcliffe, David L. Rimm, Catherine Ross, Rasmus Røge, Andreas H. Scheel, Ross A. Soo, Paul E. Swanson, Maria Tretiakova, Ka‐Fai To, Gilad W. Vainer, Hangjun Wang, Zhaolin Xu, Dirk Zielinski, Ming‐Sound Tsao
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
Yoshiko Urata, Nobuyuki Katakami, Satoshi Morita, Reiko Kaji, Hiroshige Yoshioka, Takashi Seto, Miyako Satouchi, Yasuo Iwamoto, Masashi Kanehara, Daichi Fujimoto, Norihiko Ikeda, Haruyasu Murakami, Haruko Daga, Tetsuya Oguri, Isao Goto, Fumio Imamura, Shunichi Sugawara, Hideo Saka, Naoyuki Nogami, Shunichi Negoro, Kazuhiko Nakagawa, Yoichi Nakanishi
How much of the research on Hyogo University is open access?
ScholarIQopen access share
58%OPEN ACCESS